Related Experiment Video

Updated: Jul 23, 2026

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy
10:02

A Battery of Motor Tests in a Neonatal Mouse Model of Cerebral Palsy

Published on: November 3, 2016

[Neurological impairment in children with HIV infection]

G Orejón de Luna1, F Mateos, R Simón de las Heras

  • 1Unidad de Neurologia Pediátrica, Hospital 12 de Octubre Madrid.

Revista De Neurologia
|March 1, 1996
PubMed

Insights

HIV encephalopathy significantly impacts pediatric patients, with over 20% showing neurological signs. Early detection and treatment with zidovudine offer limited, short-term benefits, highlighting poor prognosis in pediatric HIV infection.

Area of Science:

  • Pediatric Neurology
  • Infectious Diseases
  • Viral Encephalopathy

Context:

  • Retrospective analysis of 53 pediatric patients with human immunodeficiency virus (HIV) infection between 1987 and 1993.
  • Focus on the incidence and characteristics of HIV encephalopathy in a pediatric cohort.

Purpose:

  • To evaluate the occurrence and clinical presentation of HIV encephalopathy in children.
  • To analyze neurological signs, onset, neuroradiological findings, and cerebrospinal fluid abnormalities.
  • To assess the impact of zidovudine treatment and determine the prognostic significance of neurological symptoms.

Summary:

  • Eleven out of 53 pediatric patients (20.7%) developed HIV encephalopathy, primarily through vertical transmission.
  • Neurological signs, onset timing, and relationship to HIV infection stage were detailed, alongside neuroradiological and CSF findings.
  • Zidovudine treatment provided transient improvement, but the overall mortality rate was high (81.8%), indicating neurological signs as a poor prognostic factor.

Impact:

  • This study underscores the severe neurological complications of HIV in children and the limited efficacy of early treatments.
  • Highlights the critical need for improved therapeutic strategies and preventative measures for pediatric HIV infection.
  • Emphasizes that the appearance of neurological signs in pediatric HIV patients is a significant indicator of a grave prognosis.

More Related Videos

A Rat Model of EcoHIV Brain Infection08:48

A Rat Model of EcoHIV Brain Infection

Published on: January 21, 2021

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice07:23

Identification of EcoHIV-Infected Cells in Microglia-Manipulated Transgenic Mice

Published on: December 20, 2024

Related Concept Videos

Disorders of the Nervous Tissue01:28

Disorders of the Nervous Tissue

Nervous tissue is a vital component of the human body's communication system, enabling us to perceive and respond to stimuli. However, like all other tissues, it is vulnerable to disorders and diseases that can significantly impact our neurological functioning.
Homeostatic Imbalances:
Alzheimer's disease manifests as a gradual decline in memory and cognitive abilities, attributed to the buildup of amyloid plaques and neurofibrillary tangles in the brain.
Parkinson's disease arises from the...
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency disorders...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Encephalitis l: Introduction01:19

Encephalitis l: Introduction

Encephalitis is inflammation of the brain parenchyma, most often due to infections or autoimmune processes. It presents with neuropsychiatric features such as fever, altered mental status, behavioral changes, cognitive dysfunction, seizures, focal deficits, and sometimes autonomic instability. In some cases, the meninges are also involved, resulting in meningoencephalitis.Infectious CausesInfectious encephalitis is most commonly viral but can also result from bacterial, fungal, or parasitic...
Hepatic Encephalopathy01:29

Hepatic Encephalopathy

DefinitionHepatic encephalopathy is a reversible neurologic syndrome that results from advanced liver dysfunction or portosystemic shunting. It leads to disturbances in cognition, behavior, and motor function due to the brain’s exposure to gut-derived toxins that the liver fails to detoxify.EtiologyThis condition develops either in the setting of acute fulminant hepatitis or progressively during chronic liver disease, such as cirrhosis and portal hypertension. Portosystemic shunting—including...